Wolverine Trading’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.49M | Sell |
36,200
-30,900
| -46% | -$1.21M | ﹤0.01% | 2484 |
|
|
2025
Q2 | $2.59M | Sell |
67,100
-46,700
| -41% | -$1.78M | ﹤0.01% | 1507 |
|
|
2025
Q1 | $4.41M | Buy |
113,800
+74,000
| +186% | +$2.71M | 0.01% | 1058 |
|
|
2024
Q4 | $1.34M | Buy |
39,800
+11,200
| +39% | +$403K | ﹤0.01% | 2363 |
|
|
2024
Q3 | $1.16M | Buy |
+28,600
| New | +$1.17M | ﹤0.01% | 2201 |
|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$2.14M | – | 4769 |
|
|
2024
Q1 | $2.14M | Sell |
50,000
-19,200
| -28% | -$792K | ﹤0.01% | 1562 |
|
|
2023
Q4 | $2.56M | Buy |
69,200
+17,500
| +34% | +$628K | ﹤0.01% | 1535 |
|
|
2023
Q3 | $1.87M | Sell |
51,700
-22,500
| -30% | -$799K | ﹤0.01% | 1638 |
|
|
2023
Q2 | $2.63M | Buy |
74,200
+23,100
| +45% | +$829K | ﹤0.01% | 1319 |
|
|
2023
Q1 | $1.8M | Sell |
51,100
-41,200
| -45% | -$1.44M | ﹤0.01% | 1439 |
|
|
2022
Q4 | $3.24M | Sell |
92,300
-5,300
| -5% | -$177K | ﹤0.01% | 1110 |
|
|
2022
Q3 | $2.87M | Buy |
+97,600
| New | +$3.7M | ﹤0.01% | 1157 |
|
|
2022
Q2 | – | Sell |
-50,560
| Closed | -$2.76M | – | 4987 |
|
|
2022
Q1 | $2.76M | Sell |
50,560
-41,040
| -45% | -$2.23M | ﹤0.01% | 1488 |
|
|
2021
Q4 | $5.05M | Buy |
91,600
+6,000
| +7% | +$312K | 0.01% | 1144 |
|
|
2021
Q3 | $4.1M | Buy |
85,600
+35,120
| +70% | +$1.76M | ﹤0.01% | 1464 |
|
|
2021
Q2 | $2.52M | Buy |
50,480
+640
| +1% | +$30.8K | ﹤0.01% | 1745 |
|
|
2021
Q1 | $2.27M | Sell |
49,840
-46,320
| -48% | -$2.1M | ﹤0.01% | 1824 |
|
|
2020
Q4 | $4.45M | Buy |
96,160
+22,400
| +30% | +$1.03M | 0.01% | 1145 |
|
|
2020
Q3 | $3.45M | Sell |
73,760
-9,120
| -11% | -$457K | 0.01% | 1087 |
|
|
2020
Q2 | $4.22M | Sell |
82,880
-24,000
| -22% | -$1.23M | 0.01% | 912 |
|
|
2020
Q1 | $5.02M | Buy |
106,880
+33,520
| +46% | +$1.79M | 0.02% | 757 |
|
|
2019
Q4 | $4.32M | Sell |
73,360
-8,880
| -11% | -$494K | 0.01% | 1216 |
|
|
2019
Q3 | $4.35M | Sell |
82,240
-10,560
| -11% | -$543K | 0.01% | 947 |
|
|
2019
Q2 | $4.64M | Buy |
92,800
+27,680
| +43% | +$1.39M | 0.01% | 930 |
|
|
2019
Q1 | $3.4M | Sell |
65,120
-5,920
| -8% | -$296K | 0.01% | 1127 |
|
|
2018
Q4 | $3.39M | Sell |
71,040
-26,640
| -27% | -$1.31M | 0.01% | 1053 |
|
|
2018
Q3 | $4.91M | Buy |
97,680
+38,720
| +66% | +$1.97M | 0.01% | 982 |
|
|
2018
Q2 | $2.88M | Hold |
58,960
| – | – | 0.01% | 1277 |
|
|
2018
Q1 | $2.88M | Buy |
58,960
+24,720
| +72% | +$1.15M | 0.01% | 1277 |
|
|
2017
Q4 | $1.52M | Sell |
34,240
-23,520
| -41% | -$1.09M | 0.01% | 1769 |
|
|
2017
Q3 | $2.93M | Buy |
57,760
+14,000
| +32% | +$710K | 0.01% | 1087 |
|
|
2017
Q2 | $2.37M | Sell |
43,760
-7,760
| -15% | -$414K | 0.01% | 1130 |
|
|
2017
Q1 | $2.74M | Sell |
51,520
-46,240
| -47% | -$2.35M | 0.02% | 967 |
|
|
2016
Q4 | $4.71M | Sell |
97,760
-5,040
| -5% | -$249K | 0.02% | 767 |
|
|
2016
Q3 | $5.51M | Sell |
102,800
-61,280
| -37% | -$3.36M | 0.03% | 700 |
|
|
2016
Q2 | $8.71M | Buy |
+164,080
| New | +$8.64M | 0.05% | 399 |
|
Other funds holding GSK
JEST
Wolverine Trading's GSK Position: Q2 2025 in Review
Wolverine Trading sold out of GSK (GSK) in Q2 2025, closing a stake of 37,079 shares — an estimated $1.42M sold.
Wolverine Trading first reported a position in GSK in Q2 2016 and held it in 29 quarters. The position peaked at $3.41M in Q4 2021. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.
- Wolverine Trading reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 37,079 GSK shares in Q2 2025, an estimated $1.42M.
- Wolverine Trading first reported a position in GSK in Q2 2016 and held it in 29 quarters.
- Wolverine Trading's GSK position peaked at $3.41M in Q4 2021.
- 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.